In Vivo is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Dynal Biotech ASA

Division of Thermo Fisher Scientific Inc.
www.dynalbiotech.com

Latest From Dynal Biotech ASA

Norway’s Pre Diagnostics Has Alzheimer’s Test In Its Sights

Pre Diagnostics AS is a 2.5-year-old Oslo company developing a blood-based test performed by a GP and sent to a lab for early Alzheimer’s diagnosis.

Medical Device Europe

Deal Statistics Quarterly, Q1 2005

In this issue, we present another installment of our quarterly review of dealmaking-for January-March 2005. Our data comes from Windhover's Strategic Intelligence Systems, which covers deal activity within the pharmaceutical/biotechnology, medical device, and in vitro diagnostics industries.
BioPharmaceutical Medical Device

Nycomed: Changing (Private) Hands

Closed public markets didn't stop private equity group Nordic Capital from selling its investment in Denmark's Nycomed for a tidy profit. CSFB Private Equity and a group of other investors paid more than $1 billion for a firm they believe has plenty of growth potential yet.
BioPharmaceutical Europe

Xcyte Therapies Inc.

Xcyte Therapies, a company 're-started' through the 1997 merger of CDR Therapeutics and CellGenEx, is developing ex vivo cellular therapies for immune system stimulation using monoclonal antibodies conjugated to magnetic beads.
BioPharmaceutical Strategy
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
      • Genomics-Proteomics
  • In Vitro Diagnostics
  • Research, Analytical Equipment & Supplies
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Dynal AS
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Scandinavia
          • Norway
  • Parent & Subsidiaries
  • Thermo Fisher Scientific Inc.
  • Senior Management
  • Jon Hindar, Pres. & CEO
    Erik Horns, VP, Tech. Dev. & CSO
  • Contact Info
  • Dynal Biotech ASA
    Phone: (47) 22061000
    Ullernchausseen 52
    0379 Oslo,
    Norway
Advertisement
Advertisement
UsernamePublicRestriction

Register